St. Vincent's Hospital Melbourne

Darlinghurst 2010

1 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Leukemia

Studies at this site

• Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission — Recruiting now
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling